AU Stock MarketDetailed Quotes

IMC Immuron Ltd

Watchlist
  • 0.084
  • 0.0000.00%
20min DelayMarket Closed Dec 11 10:12 AET
19.15MMarket Cap-2.80P/E (Static)

About Immuron Ltd Company

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Company Profile

SymbolIMC
Company NameImmuron Ltd
Founded1994
MarketASX
Employees7
Fiscal Year Ends06-30
AddressChapman Street Unit 10, 25-37
CityMelbourne
CountryAustralia
Zip Code3130
Phone+61 398245254
Websitehttps://www.immuron.com.au
Share RegistryAUTOMIC REGISTRY SERVICES Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000 02 9698 5414

Company Executives

  • Name
  • Position
  • Salary
  • Steven Lydeamore
  • Chief Executive Officer
  • 599.14K
  • Dr. Jerry Kanellos, PhD
  • Chief Scientific Officer
  • 359.25K
  • Flavio Palumbo
  • Chief Commercial Officer
  • 347.61K
  • Phillip A. Hains
  • Chief Financial Officer and Secretary
  • --
  • Paul Brennan
  • Chairman of the Board
  • 153.60K
  • Professor Ravi Savarirayan
  • Independent Director
  • 75.00K
  • Dr. Jeannette Joughin
  • Independent Director
  • 7.55K
  • Daniel Pollock
  • Independent Director
  • 127.65K
Heat List
AU
Overall
Symbol
Price
% Chg

No Data